Table 3.
OR | 95% CI | p-value | ||
---|---|---|---|---|
Clinical Assessment: timely review (Yes vs No)* | ||||
Consultant review within 6 h | 1.13 | 0.83 | 1.55 | 0.43 |
Medication review (dose adjustments and discontinuation within 6 h) | 0.95 | 0.65 | 1.39 | 0.80 |
Fluid balance assessment (Fluid balance assessment within 6 h) | 1.16 | 0.74 | 1.81 | 0.51 |
Urinalysis test recorded | 0.52 | 0.38 | 0.71 | <0.0001 |
USS renal tract [within 24 hrs (<6 h if pyelo) or any other imaging to exclude obstruction] | 0.68 | 0.49 | 0.94 | 0.020 |
Blood/gas acid-base recorded | 1.64 | 1.15 | 2.34 | 0.006 |
Clinical management: timely Interventions - treatment completed (Y vs N) when indicated⁎⁎ | ||||
Antibiotics (Within 1 h) | 0.73 | 0.41 | 1.28 | 0.26 |
IV fluids | 1.17 | 0.42 | 3.22 | 0.77 |
Bladder catheterisation | 1.74 | 0.73 | 4.16 | 0.21 |
Follow-up: Discharge letter - TTO - if alive at discharge (Y vs N)⁎⁎⁎ | ||||
AKI mentioned on discharge letter | 0.73 | 0.27 | 2.01 | 0.54 |
GP Instructions re medicine and blood tests on discharge letter | 0.98 | 0.38 | 2.55 | 0.96 |
Follow-up of unresolved renal function mentioned on discharge letter | 0.57 | 0.19 | 1.70 | 0.31 |
some people not included because of missing data on the variable of interest (minimum cohort n=931)
people excluded mainly because ‘not-indicated’ (minimum cohort n=506)
people excluded if died in hospital or if ‘not-indicated’ (minimum cohort n=340)